Company Profiles

driven by the PitchBook Platform

Ora Bio

2005 FOUNDED
OOB STATUS
Out of Business LATEST DEAL TYPE
Description

Developer of drugs designed to treat lung cancer. The company's drugs include two products such as the ORA101 for non-small cell lung cancer and ORA102 for age-related macular degeneration, enabling doctors to treat lung cancer.

Website:
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
P.O. Box 1252
Nazareth Illit 17000
Israel
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ora Bio’s full profile, request a free trial.

Ora Bio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Jan-2015 Completed Out of Business
1. Accelerator/Incubator 30-May-2006 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Ora Bio Executive Team (1)

Name Title Board
Seat
Contact
Info
Josef Israeli Co-Founder & Chief Executive Officer

Ora Bio Board Members (1)

Name Representing Role Since Contact
Info
Gary Jacobs Ora Bio Chairman 000 0000